Local irradiation prior to stem cell harvest has no influence on CD34+ yield: A quantitative analysis

Annals of Hematology

Volumn 85, Issue 1, 2006, Pages 38-44

  Rinn, J P ^a   Schwella, N ^a   Wollmer, E ^a   Jaques, G ^a   Heinzel Gutenbrunner, M ^a   Strassmann, G ^a   Gross, M W ^a   Movassaghi, K ^b   Neubauer, A ^a   Ritter, Markus ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Autologous transplantation; Local irradiation; Mobilization; Multiple myeloma plasmocytoma

Indexed keywords

ANTINEOPLASTIC AGENT; CARMUSTINE; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; MELPHALAN; PREDNISOLONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINCRISTINE;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BONE MARROW TOXICITY; CANCER RADIOTHERAPY; CELL DENSITY; DRUG MEGADOSE; FEMALE; HUMAN; LEUKAPHERESIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION EXPOSURE; STEM CELL MOBILIZATION;

ADULT; AGED; ANTIGENS, CD34; CELL COUNT; CYCLOPHOSPHAMIDE; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKAPHERESIS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; RADIATION DOSAGE; RETROSPECTIVE STUDIES; TRANSPLANTATION, AUTOLOGOUS;

EID: 28944441541     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-005-1078-5     Document Type: Article

References (31)

1. Alexanian R, Haut A, Khan AU, Lane M, McKelvey EM, Migliore PJ et al (1969) Treatment for multiple myeloma. Combination chemotherapy with different melphalan dose regimens. JAMA 208:1680-1685 10.1001/ jama.208.9.1680
2. Atkinson HR (1962) Bone marrow distribution as a factor in estimating radiation to the blood-forming organ: A survey of present knowledge. J Coll Radiol Australas 6:149-154 13965364
3. Attal M, Harousseau JL, Facon T, Guilhot F, Doyen C, Fuzibet JG et al (2003) Single versus double autologous stem-cell transplantation for multiple myeloma. N Engl J Med 349:2495-2502 10.1056/NEJMoa032290
4. Attal M, Harousseau JL, Stoppa AM, Sotto JJ, Fuzibet JG, Rossi JF et al (1996) A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome. N Engl J Med 335:91-97 10.1056/NEJM199607113350204
5. Beguin Y, Baudoux E, Sautois B, Fraipont V, Schaaf-Lafontaine N, Pereira M et al (1998) Hematopoietic recovery in cancer patients after transplantation of autologous peripheral blood CD34+ cells or unmanipulated peripheral blood stem and progenitor cells. Transfusion 38:199-208 10.1046/j.1537-2995.1998.38298193106.x
6. Bensinger W, Appelbaum F, Rowley S, Storb R, Sanders J, Lilleby K et al (1995) Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Oncol 13:2547-2555 7595706
7. Bensinger WI, Rowley SD, Demirer T, Lilleby K, Schiffman K, Clift RA et al (1996) High-dose therapy followed by autologous hematopoietic stem-cell infusion for patients with multiple myeloma. J Clin Oncol 14:1447-1456 8622058
8. Canales MA, Arrieta R, Hernandez-Garcia MC, Ojeda E, Diez J, Calero F et al (2000) Factors influencing collection and engraftment of CD34+ cells in patients with breast cancer following high-dose chemotherapy and autologous peripheral blood progenitor cell transplantation. J Hematother Stem Cell Res 9:103-109 10.1089/152581600319685
9. Corso A, Caberlon S, Pagnucco G, Klersy C, Zappasodi P, Alessandrino EP et al (2000) Blood stem cell collections in multiple myeloma: Definition of a scoring system. Bone Marrow Transplant 26:283-286 10.1038/ sj.bmt.1702514
10. Demirer T, Buckner CD, Gooley T, Appelbaum FR, Rowley S, Chauncey T et al (1996) Factors influencing collection of peripheral blood stem cells in patients with multiple myeloma. Bone Marrow Transplant 17:937-941 8807097
11. Dreger P, Kloss M, Petersen B, Haferlach T, Loffler H, Loeffler M et al (1995) Autologous progenitor cell transplantation: Prior exposure to stem cell-toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow grafts. Blood 86:3970-3978 7579368
12. Durie B, Salmon S (1975) A clinical staging system for multiple myeloma: correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer 36:842-854 1182674
13. Ellis RE (1961) The distribution of active bone marrow in the adult. Phys Med Biol 5:255-258 10.1088/0031-9155/5/3/302
14. Fruehauf S, Schmitt K, Veldwijk MR, Topaly J, Benner A, Zeller WJ et al (1999) Peripheral blood progenitor cell (PBPC) counts during steady-state haemopoiesis enable the estimation of the yield of mobilized PBPC after granulocyte colony-stimulating factor supported cytotoxic chemotherapy: An update on 100 patients. Br J Haematol 105:786-794 10.1046/j.1365-2141.1999.01405.x
15. 2) and granulocyte colony-stimulating factor in patients with multiple myeloma. Bone Marrow Transplant 17:691-697 8733683
16. Goldschmidt H, Hegenbart U, Wallmeier M, Hohaus S, Haas R (1997) Factors influencing collection of peripheral blood progenitor cells following high-dose cyclophosphamide and granulocyte colony-stimulating factor in patients with multiple myeloma. Br J Haematol 98:736-744 10.1046/ j.1365-2141.1997.2783095.x
17. Haas R, Mohle R, Fruhauf S, Goldschmidt H, Witt B, Flentje M et al (1994) Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 83:3787-3794 7515721
18. Kobbe. G, Sohngen D, Bauser U, Schneider P, Germing U, Thiele KP et al (1999) Factors influencing G-CSF-mediated mobilization of hematopoietic progenitor cells during steady-state hematopoiesis in patients with malignant lymphoma and multiple myeloma. Ann Hematol 78:456-462 10.1007/ s002770050598
19. Kricun ME. (1985) Red-yellow marrow conversion: Its effect on the location of some solitary bone lesions. Skeletal Radiol 14:10-19 10.1007/ BF00361188
20. Kroger N, Zeller W, Hassan HT, Kruger W, Renges H, Hummel K et al (1998) Successful mobilization of peripheral blood stem cells in heavily pretreated myeloma patients with G-CSF alone. Ann Hematol 76:257-262 10.1007/s002770050398
21. Majolino I, Marceno R, Buscemi F, Scime R, Vasta S, Indovina A et al (1995) Mobilization of circulating progenitor cells in multiple myeloma during VCAD therapy with or without rhG-CSF. Haematologica 80:108-114 7543068
22. Marit G, Thiessard F, Faberes C, Cony-Makhoul P, Boiron JM, Bernard P et al (1998) Factors affecting both peripheral blood progenitor cell mobilization and hematopoietic recovery following autologous blood progenitor cell transplantation in multiple myeloma patients: A monocentric study. Leukemia 12:1447-1456 10.1038/sj.leu.2401105
23. Mauch P, Constine L, Greenberger J, Knospe W, Sullivan J, Liesveld JL et al (1995) Hematopoietic stem cell compartment: Acute and late effects of radiation therapy and chemotherapy. Int J Radiat Oncol Biol Phys 31:1319-1339 10.1016/0360-3016(94)00430-S
24. Moehler TM, Neben K, Benner A, Egerer G, Krasniqi F, Ho AD et al (2001) Salvage therapy for multiple myeloma with thalidomide and CED chemotherapy. Blood 98:3846-3848 10.1182/blood.V98.13.3846
25. Parmentier C, Morardet N, Tubiana M (1983) Late effects on human bone marrow after extended field radiotherapy. Int J Radiat Oncol Biol Phys 9:1303-1311 6885543
26. Perea G, Sureda A, Martino R, Altes A, Martinez C, Cabezudo E et al (2001) Predictive factors for a successful mobilization of peripheral blood CD34+ cells in multiple myeloma. Ann Hematol 80:592-597 10.1007/ s002770100351
27. Prince HM, Imrie K, Sutherland DR, Keating A, Meharchand J, Crump RM et al (1996) Peripheral blood progenitor cell collections in multiple myeloma: Predictors and management of inadequate collections. Br J Haematol 93:142-145 10.1046/j.1365-2141.1996.448987.x
28. Rubin P, Landman S, Mayer E, Keller B, Ciccio S (1973) Bone marrow regeneration and extension after extended field irradiation in Hodgkin's disease. Cancer 32:699-711 4726969
29. Schmitz N, Pfistner B, Sextro M, Sieber M, Carella AM, Haenel M et al (2002) Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: A randomised trial. Lancet 359:2065-2071 10.1016/S0140-6736(02)08938-9
30. Tricot G, Jagannath S, Vesole D, Nelson J, Tindle S, Miller L et al (1995) Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients. Blood 85:588-596 7529066
31. Williamson DF, Parker RA, Kendrick JS (1989) The box plot: A simple visual method to interpret data. Ann Intern Med 110:916-921 2719423